Impact of Precision-Guided Dosing on Clinical Decision-Making and Health Care Utilization in Inflammatory Bowel Disease: A Retrospective Pretest/Posttest Real-World Study
HCPs used the PGD test to guide treatment decisions. PGD-driven optimization of IFX therapy led to improved patient outcomes, lower healthcare utilization, and cost savings.
Authors
- Adria A. Condino
- Stephen B. Hanauer (ORCID: https://orcid.org/0000-0002-3268-932X)
- Bincy Abraham (ORCID: https://orcid.org/0000-0003-0308-1224)
- Donald Lum
- Terrence A. Barrett (ORCID: https://orcid.org/0000-0001-6428-3271)
- Esther A. Torres (ORCID: https://orcid.org/0000-0002-1276-0731)
- David Ziring (ORCID: https://orcid.org/0000-0002-5318-9906)
- Udayakumar Navaneethan (ORCID: https://orcid.org/0000-0002-7677-0349)
- Thierry Dervieux (ORCID: https://orcid.org/0000-0002-3799-4438)
- Ronen Arai
- Syed Adeel Hassan (ORCID: https://orcid.org/0000-0002-8484-0319)
- Harry Bray
- Patricia Aragon Han
- Timothy E. Ritter
Institutions
- Northwestern University (US)
- OhioHealth (US)
- Cedars-Sinai Medical Center (US)
- University of Kentucky (US)
- Orlando Health (US)
- University of Puerto Rico System (PR)
- Cornell University (US)
- University of Michigan (US)
- National University of San Juan (AR)
- Prometheus Biosciences (United States) (US)
- Nutrition 21 (United States) (US)
- San Juan City Hospital (PR)
- Prometheus Research (United States) (US)
- Oregon Clinic (US)
- Methodist Hospital (US)
- Z Urology (US)
- The King's University (US)
- Prometheus (United States) (US)
- Nutrition Sciences (Belgium) (BE)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1093/crocol/otaf044
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00